An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma

American Journal of Dermatopathology

Volumn 18, Issue 4, 1996, Pages 367-370

  Bergman, Reuven ^a,b   Ramon, Michal ^a   Kilim, Sigalit ^a   Lichtig, Chaim ^a,b   Friedman Birnbaum, Rachel ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Classical; Immunohistochemistry; Kaposi; p53 protein

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; SARCOMA, KAPOSI; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029796243     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199608000-00007     Document Type: Article

References (24)

1. Campbell C, Quinn AG, Ro Y-S, Angus B, Rees JL. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 1993;100:746-8.
2. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-8.
3. Bártek J, Bártková J, Vojtěšek B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991;6:1699-703.
4. Levine AJ, Momand J, Finlay CA. The p53 tumour suppression gene. Nature 1991;351:453-6.
5. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10,124-8.
6. Rady P, Scinicariello F, Wagner RF, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res 1992;52:3804-6.
7. Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog 1991;4:445-9.
8. Shea CR, McNutt NS, Volkenandt M, Lugo J, Prioleau PG, Albino AP. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol 1992;141:25-9.
9. Stephenson TJ, Royds J, Silcocks PB, Blechen SS. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol 1992;127:566-70.
10. McGregor JM, Yu CC-W, Dublin EA, Levison DA, MacDonald DM. Aberrant expression of p53 tumour-suppression protein in non-melanoma skin cancer. Br J Dermatol 1992;127:463-9.
11. Sim CS, Slater S, McKee PH. Mutant p53 expression in solar keratosis: an immunohistochemical study. J Cutan Pathol 1992;19:302-8.
12. Sim CS, Slater SD, McKee PH. Mutant p53 protein is expressed in Bowen's disease. Am J Dermatopathol 1992;14:195-9.
13. McGregor JM, Yu CC-W, Dublin EA, Barnes DM, Levison DA. MacDonald DM. p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br J Dermatol 1993;128:606-11.
14. Scinicariello F, Dolan MJ, Nedelcu I, Tyring SK, Halliard JK. Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma. Virology 1994;203:153-7.
15. Armes J. A review of Kaposi's sarcoma. Adv Cancer Res 1989;53:73-87.
16. Harawi SJ. Kaposi's sarcoma. In: Harawi SJ, O'Hara CJ, eds. Pathology and pathophysiology of AIDS and HIV-related diseases. St Louis: CV Mosby, 1989:83-131.
17. Friedman-Birnbaum R, Bergman R, Bitterman-Deutsch O, Weltfriend S, Lichtig C. Classical and iatrogenic Kaposi's sarcoma: histopathological patterns as related to clinical course. Am J Dermatopathol 1993;15:523-7.
18. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
19. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.
20. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papil- lomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
21. Scinicariello F, Rady P, Cloyd MW, Tyring SK. HPV 18 in HIV-associated Kaposi's sarcoma [Letter]. Lancet 1991;337:501.
22. Huang YQ, Li JJ, Rush MG, et al. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 1992;339:515-8.
23. Biggar RJ, Dunsmore N, Kurman RJ, et al. Failure to detect human papillomavirus in Kaposi's sarcoma. Lancet 1992;339:1604-5.
24. Ackerman AB, Ragaz A. The lives of lesions. New York: Masson, 1984.